Literature DB >> 7831297

Evidence for two distinct retinoic acid response pathways for HOXB1 gene regulation.

T Ogura1, R M Evans.   

Abstract

We have recently identified a promoter proximal retinoic acid (RA)-responsive site in the 5' region of the HOXB1 gene. In this report, we have identified the second RA-responsive site in the 3' region of the HOXB1 gene. This site also consists of a DR-2-type target of RA receptor.retinoid X receptor complex (DR-2B) and the binding site for a distinct RA-dependent coactivator termed retinoid-activating protein, which shows a different tissue-specific spectrum from the 5' responsive site. This indicates that the activation of the HOXB1 gene is achieved through two distinct pathways. These data define an unusual regulatory mechanism leading to the establishment of HOXB1 gene expression.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7831297      PMCID: PMC42746          DOI: 10.1073/pnas.92.2.392

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  14 in total

1.  RXR beta: a coregulator that enhances binding of retinoic acid, thyroid hormone, and vitamin D receptors to their cognate response elements.

Authors:  V C Yu; C Delsert; B Andersen; J M Holloway; O V Devary; A M Näär; S Y Kim; J M Boutin; C K Glass; M G Rosenfeld
Journal:  Cell       Date:  1991-12-20       Impact factor: 41.582

2.  Differential regulation by retinoic acid of the homeobox genes of the four HOX loci in human embryonal carcinoma cells.

Authors:  A Simeone; D Acampora; V Nigro; A Faiella; M D'Esposito; A Stornaiuolo; F Mavilio; E Boncinelli
Journal:  Mech Dev       Date:  1991-03       Impact factor: 1.882

3.  Characterization of an autoregulated response element in the mouse retinoic acid receptor type beta gene.

Authors:  H M Sucov; K K Murakami; R M Evans
Journal:  Proc Natl Acad Sci U S A       Date:  1990-07       Impact factor: 11.205

4.  Pluripotent embryonal carcinoma clones derived from the human teratocarcinoma cell line Tera-2. Differentiation in vivo and in vitro.

Authors:  P W Andrews; I Damjanov; D Simon; G S Banting; C Carlin; N C Dracopoli; J Føgh
Journal:  Lab Invest       Date:  1984-02       Impact factor: 5.662

5.  Retinoid X receptor is an auxiliary protein for thyroid hormone and retinoic acid receptors.

Authors:  X K Zhang; B Hoffmann; P B Tran; G Graupner; M Pfahl
Journal:  Nature       Date:  1992-01-30       Impact factor: 49.962

6.  Purification, cloning, and RXR identity of the HeLa cell factor with which RAR or TR heterodimerizes to bind target sequences efficiently.

Authors:  M Leid; P Kastner; R Lyons; H Nakshatri; M Saunders; T Zacharewski; J Y Chen; A Staub; J M Garnier; S Mader
Journal:  Cell       Date:  1992-01-24       Impact factor: 41.582

7.  Sequential activation of HOX2 homeobox genes by retinoic acid in human embryonal carcinoma cells.

Authors:  A Simeone; D Acampora; L Arcioni; P W Andrews; E Boncinelli; F Mavilio
Journal:  Nature       Date:  1990-08-23       Impact factor: 49.962

8.  Expression of the mouse labial-like homeobox-containing genes, Hox 2.9 and Hox 1.6, during segmentation of the hindbrain.

Authors:  P Murphy; R E Hill
Journal:  Development       Date:  1991-01       Impact factor: 6.868

9.  A retinoic acid response element is present in the mouse cellular retinol binding protein I (mCRBPI) promoter.

Authors:  W C Smith; H Nakshatri; P Leroy; J Rees; P Chambon
Journal:  EMBO J       Date:  1991-08       Impact factor: 11.598

10.  Retinoid X receptor interacts with nuclear receptors in retinoic acid, thyroid hormone and vitamin D3 signalling.

Authors:  S A Kliewer; K Umesono; D J Mangelsdorf; R M Evans
Journal:  Nature       Date:  1992-01-30       Impact factor: 49.962

View more
  8 in total

1.  Segment-specific pattern of sympathetic preganglionic projections in the chicken embryo spinal cord is altered by retinoids.

Authors:  C J Forehand; E B Ezerman; J P Goldblatt; D L Skidmore; J C Glover
Journal:  Proc Natl Acad Sci U S A       Date:  1998-09-01       Impact factor: 11.205

2.  A nuclear hormone receptor corepressor mediates transcriptional silencing by receptors with distinct repression domains.

Authors:  I Zamir; H P Harding; G B Atkins; A Hörlein; C K Glass; M G Rosenfeld; M A Lazar
Journal:  Mol Cell Biol       Date:  1996-10       Impact factor: 4.272

Review 3.  HOX genes: Major actors in resistance to selective endocrine response modifiers.

Authors:  Kideok Jin; Saraswati Sukumar
Journal:  Biochim Biophys Acta       Date:  2016-01-22

4.  A retinoic acid-triggered cascade of HOXB1 gene activation.

Authors:  T Ogura; R M Evans
Journal:  Proc Natl Acad Sci U S A       Date:  1995-01-17       Impact factor: 11.205

Review 5.  The new dysmorphology: application of insights from basic developmental biology to the understanding of human birth defects.

Authors:  C J Epstein
Journal:  Proc Natl Acad Sci U S A       Date:  1995-09-12       Impact factor: 11.205

6.  Analysis of dynamic changes in retinoid-induced transcription and epigenetic profiles of murine Hox clusters in ES cells.

Authors:  Bony De Kumar; Mark E Parrish; Brian D Slaughter; Jay R Unruh; Madelaine Gogol; Christopher Seidel; Ariel Paulson; Hua Li; Karin Gaudenz; Allison Peak; William McDowell; Brian Fleharty; Youngwook Ahn; Chengqi Lin; Edwin Smith; Ali Shilatifard; Robb Krumlauf
Journal:  Genome Res       Date:  2015-05-29       Impact factor: 9.043

7.  HOXB1 restored expression promotes apoptosis and differentiation in the HL60 leukemic cell line.

Authors:  Marina Petrini; Federica Felicetti; Lisabianca Bottero; Maria Cristina Errico; Ornella Morsilli; Alessandra Boe; Alessandra De Feo; Alessandra Carè
Journal:  Cancer Cell Int       Date:  2013-10-22       Impact factor: 5.722

8.  Primary culture of avian embryonic heart forming region cells to study the regulation of vertebrate early heart morphogenesis by vitamin A.

Authors:  Inese Cakstina; Una Riekstina; Martins Boroduskis; Ilva Nakurte; Janis Ancans; Maija H Zile; Indrikis Muiznieks
Journal:  BMC Dev Biol       Date:  2014-02-19       Impact factor: 1.978

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.